Previous studies have investigated the clinical performance of the Siemens Biograph Vision in terms of the image quality and the lesion detection rates for oncological patients investigated with 18F-FDG-PET/CT [18] and the lesion detection rates for recurrent prostate cancer patients investigated with 68Ga-PSMA-11 PET/CT [19] and found the digital scanner to outperform its analog counterparts. This evidence concerns the gene FOLH1 and prostate carcinoma.